Last Updated on October 17, 2024 by The Health Master
Granules India yesterday announced that Granules Pharmaceuticals, a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, USA, has cleared a pre-approval inspection (PAI) for three of its applications filed from this facility.
The company, had undergone the PAI audit by the US Food and Drug Administration (USFDA) from 21st June, 2021 to 25th June, 2021. The USFDA has issued two minor observations during the audit.
Speaking in this regard, Priyanka Chigurupati, Executive Director, GPI, said, “The observations were responded to within the stipulated time, and we are happy to inform that the USFDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th July, 2021.
This is the fifth USFDA audit for this facility.”
Zydus Cadila gets USFDA nod for Ibrutinib tablets
Lupin gets USFDA nod for generic Antifungal drug
Unichem gets tentative USFDA nod for drug to treat Diabetes
Alembic gets USFDA final nod for Erlotinib Tablets
Alembic gets USFDA nod for drug for the treatment of Depression
USFDA approves Abbott’s Stent to treat high bleeding risk patients
Procedure to obtain license for manufacturing of drugs
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
NPPA fixes retail prices of 14 formulations
High Court asks petitioner to move Drugs Inspector
APIs: Active Raw Materials for these Drugs get costlier by 139%
India and Pharmacy Education: Chapter:1
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
